Effects of Nordic walking in Alzheimer’s disease: A single-blind randomized controlled clinical trial
5 Apr 2025
This single-blind randomized clinical trial evaluated the effects of a 24-week Nordic Walking (NW) intervention in patients with mild to moderate Alzheimer’s disease (AD). Thirty patients were assigned to either a control group receiving standard cognitive and physical therapies or an experimental group that also engaged in NW training twice a week. After 24 weeks, the NW group showed significant improvements in cognitive functions, including visual-spatial reasoning, verbal episodic memory, selective attention, and processing speed. Although MMSE scores did not significantly differ between groups, the intervention group maintained cognitive function while the control group showed decline. These findings suggest that NW may be an effective and accessible addition to therapeutic strategies for slowing cognitive decline in early-stage AD.
You may be interested in them
21 Oct 2025
Effect of Nordic Walking on Walking Ability in Patients with Peripheral Arterial Disease
21 Oct 2025
Effects of Nordic Walking on Physical Fitness in Patients with Cancer: A Systematic Review
21 Oct 2025
Nordic Walking Groups for People with Parkinson’s Disease in Community Rehabilitation Settings
World Original Nordic Walking Federation
Administration office:
JĘDRZYCHOWSKA 20D
65-385 ZIELONA GÓRA, POLAND
office@onwf.org
© 2024 onwf.org | Original Nordic Walking from Finland